Work

A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.6072

Authors: Marcia S. Brose, Andrea B. Troxel, Mark Yarchoan, Aaron Benjamin Cohen, Kathleen Harlacker, Nikolas A Dyanick, Zakkiyya A Posey, Ramkrishna Makani, Parna Prajapati, Larisa M. Zifchak, Carolyn Grande, Christian Michael Squillante

Institutions: Abramson Cancer Center, University of Pennsylvania, Hospital of the University of Pennsylvania

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600687328

Cites:

Cited by: 21

Related to: 10